The percentage of iNOS- (p < 0.001, Figure 2a) and eNOS-positive (p < 0.01, Figure 2a) cells were significantly higher in patients with CML compared to healthy subjects. This evidence concerns the gene NOS3 and chronic myelogenous leukemia, BCR-ABL1 positive.